Business Segments Boston Scientific Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 17:47:52 10/04/2026 BST			5-day change	1st Jan Change
61.21 ^USD	-0.11%		-2.17%	-35.78%

04-09	Terumo Deepens Costa Rica Investment Amid Medtech Growth	MT
04-08	Goldman Sachs Adjusts Price Target on Boston Scientific to $87 From $93, Maintains Buy Rating	MT

Breakdown by Business Segment (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
Therapeutic Devices
Cardiovascular (Incl. Rhythm)	4.86B	7.83B	8.82B	10.76B	13.25B
Total Assets	2.82B	5.2B	5.99B	7.08B	8B
D&A	167M	245M	263M	302M	355M
Operating Income	1.45B	2.11B	2.24B	3.15B	4.3B
MedSurg	3.72B	4.91B	5.42B	5.99B	6.82B
Total Assets	1.79B	2.5B	2.89B	3.09B	3.39B
D&A	81M	88M	103M	110M	115M
Operating Income	1.4B	1.62B	1.8B	2.05B	2.27B
Rhythm and Neuro	3.29B	-	-	-	-
Total Assets	1.98B	-	-	-	-
D&A	104M	-	-	-	-
Operating Income	607M	-	-	-	-
Rhythm Management	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceutical Products
Specialty Pharmaceuticals	13M	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	4M	-	-	-	-
Other	-	-60M	-	-	-
Operating Income	-	-60M	-	-	-
D&A	-	-	-	-	-
Operating Income	-447M	-436M	-293M	-663M	-958M
Total Assets	11.99B	12.92B	14.39B	17.09B	18.28B
Total Assets	6.12B	5.9B	6B	6.68B	7.02B
Total Assets	7.52B	5.94B	5.87B	5.45B	6.98B

Geographical breakdown of sales (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
United States (U.S.)	6.91B	7.63B	8.42B	10.21B	12.86B
Total Assets	1.19B	1.24B	1.3B	1.46B	1.92B
Europe, Middle East and Africa (EMEA)	2.52B	2.53B	2.86B	3.23B	3.45B
Asia-Pacific (APAC)	2.07B	2.12B	2.4B	2.69B	3.08B
Latin America and Canada (LACA)	386M	469M	560M	624M	678M
Total Assets	18.54B	19.21B	20.83B	24.22B	25.77B
Total Assets	-	246M	373M	530M	637M
International	4M	-	-	-	-
Total Assets	-	-	-	-	-
Total Assets	-	-	-	-	-
Other Countries	-	-60M	-	-	-
Total Assets	625M	481M	587M	672M	730M
Total Assets	436M	478M	598M	631M	750M
Japan	-	-	-	-	-